| NANOBIOTIX INH. EO-,03 |
| Frankreich |
| Gesundheit |
| FR0011341205 / A1J7EB |
| 5NR (Frankfurt) |
| FRA:5NR, ETR:5NR, 5NR:GR |
| - |
| https://www.nanobiotix.co.. |
|
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United..
>Volltext.. |
| 1249.24 Mio. EUR |
| 1271.67 Mio. EUR |
| - |
| - |
| - |
| - |
| 52.01 Mio. EUR |
| 29.25 Mio. EUR |
| - |
| 0.46 |
| - |
| - |
| - |
| - |
| - |
| - |
| NANOBIOTIX |
| 25.03.26 |
|
||||
|
||||
|
||||
|
||||
|